1. Home
  2. BDRX vs DFLI Comparison

BDRX vs DFLI Comparison

Compare BDRX & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDRX
  • DFLI
  • Stock Information
  • Founded
  • BDRX 2000
  • DFLI 2020
  • Country
  • BDRX United Kingdom
  • DFLI United States
  • Employees
  • BDRX N/A
  • DFLI N/A
  • Industry
  • BDRX Biotechnology: Pharmaceutical Preparations
  • DFLI Electronic Components
  • Sector
  • BDRX Health Care
  • DFLI Technology
  • Exchange
  • BDRX Nasdaq
  • DFLI Nasdaq
  • Market Cap
  • BDRX 5.8M
  • DFLI 5.0M
  • IPO Year
  • BDRX N/A
  • DFLI N/A
  • Fundamental
  • Price
  • BDRX $7.02
  • DFLI $0.26
  • Analyst Decision
  • BDRX
  • DFLI Strong Buy
  • Analyst Count
  • BDRX 0
  • DFLI 1
  • Target Price
  • BDRX N/A
  • DFLI $1.50
  • AVG Volume (30 Days)
  • BDRX 147.7K
  • DFLI 46.6M
  • Earning Date
  • BDRX 09-29-2025
  • DFLI 08-14-2025
  • Dividend Yield
  • BDRX N/A
  • DFLI N/A
  • EPS Growth
  • BDRX N/A
  • DFLI N/A
  • EPS
  • BDRX N/A
  • DFLI N/A
  • Revenue
  • BDRX N/A
  • DFLI $51,496,000.00
  • Revenue This Year
  • BDRX N/A
  • DFLI $30.09
  • Revenue Next Year
  • BDRX N/A
  • DFLI $50.08
  • P/E Ratio
  • BDRX N/A
  • DFLI N/A
  • Revenue Growth
  • BDRX N/A
  • DFLI N/A
  • 52 Week Low
  • BDRX $5.85
  • DFLI $0.15
  • 52 Week High
  • BDRX $166.93
  • DFLI $6.21
  • Technical
  • Relative Strength Index (RSI)
  • BDRX 31.98
  • DFLI 48.32
  • Support Level
  • BDRX $5.85
  • DFLI $0.22
  • Resistance Level
  • BDRX $8.75
  • DFLI $0.27
  • Average True Range (ATR)
  • BDRX 0.62
  • DFLI 0.07
  • MACD
  • BDRX -0.12
  • DFLI -0.00
  • Stochastic Oscillator
  • BDRX 32.02
  • DFLI 20.62

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a highly cost-effective storage solution.

Share on Social Networks: